Keros Therapeutics, Inc.KROSNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 20 | 0 | 0 | 4↑2251.0% |
| Gross Profit | -1 | 20↑3422.3% | 0 | 0 | 4↑2251.0% |
| Operating Income | -47 | -56↓20.8% | -115↓103.6% | -170↓48.0% | -211↓24.1% |
| Net Income | -45 | -59↓29.5% | -105↓78.2% | -153↓46.2% | -187↓22.5% |
| EBITDA | -45 | -56↓25.4% | -104↓84.6% | -152↓46.3% | -186↓22.1% |
| EPS Diluted | -2.93 | -2.52↑14.0% | -4.15↓64.7% | -5.20↓25.3% | -5.00↑3.8% |